$FHLD
Freedom Holdings, Inc.

2023 Q3 Form 10-K Financial Statement

#000147793224000342 Filed on January 24, 2024

View on sec.gov

Income Statement

Concept 2023 Q3 2023
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.076K
YoY Change -10.77%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $395.5K
YoY Change 419.8%
Operating Profit -$395.5K
YoY Change 419.8%
Interest Expense $11.84K
YoY Change -6.15%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$399.9K
YoY Change 548.19%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 55.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $588.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $588.00
YoY Change 232.2%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $588.00
Total Long-Term Assets $0.00
Total Assets $588.00
YoY Change 232.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $44.50K
YoY Change -0.42%
Accrued Expenses $241.3K
YoY Change -0.97%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $286.1K
YoY Change -10.71%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $126.4K
YoY Change 37.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $286.1K
Total Long-Term Liabilities $126.4K
Total Liabilities $412.5K
YoY Change -0.04%
SHAREHOLDERS EQUITY
Retained Earnings -$10.18M
YoY Change 4.09%
Common Stock $5.531K
YoY Change 494.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$411.9K
YoY Change
Total Liabilities & Shareholders Equity $588.00
YoY Change 232.2%

Cashflow Statement

Concept 2023 Q3 2023
OPERATING ACTIVITIES
Net Income -$399.9K
YoY Change 548.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$51.71K
YoY Change 86.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $52.12K
YoY Change 101.85%
NET CHANGE
Cash From Operating Activities -$51.71K
Cash From Investing Activities
Cash From Financing Activities $52.12K
Net Change In Cash $411.00
YoY Change -121.02%
FREE CASH FLOW
Cash From Operating Activities -$51.71K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
286127 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
126350 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
123733 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
126350 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
123733 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
330 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
288915 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001386044
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-54853
CY2023 dei Entity Registrant Name
EntityRegistrantName
Freedom Holdings, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
10524 Independence Ave
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Chatsworth
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91311
CY2023 dei City Area Code
CityAreaCode
818
CY2023 dei Local Phone Number
LocalPhoneNumber
357-3155
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
13274118 usd
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55308825 shares
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
574 usd
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
5500 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
40380 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
71510 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4076 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4568 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
395456 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
76078 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-395456 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-76078 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7382 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
27000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-399918 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2023 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.01
CY2022 fhld Basic And Diluted Loss Per Share
BasicAndDilutedLossPerShare
-0.00
CY2023 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
37199236 shares
CY2022 fhld Weighted Average Number Of Shares Outstanding
WeightedAverageNumberOfSharesOutstanding
160376744 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-349792 usd
CY2022 fhld Conversion Of Preferred Shares Into Common Amount
ConversionOfPreferredSharesIntoCommonAmount
-1 usd
CY2022 fhld Cancellation Of Common Shares Amount
CancellationOfCommonSharesAmount
-980 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-61698 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
CY2023 fhld Issued Stock For Acquisition Amount
IssuedStockForAcquisitionAmount
44500 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
351000 usd
CY2023 fhld Sold Common Stock Amount
SoldCommonStockAmount
5000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-399918 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-411889 usd
CY2023 us-gaap Profit Loss
ProfitLoss
399918 usd
CY2022 us-gaap Profit Loss
ProfitLoss
61698 usd
CY2023 fhld Stock Issued During Period Issued For Services
StockIssuedDuringPeriodIssuedForServices
-351000 usd
CY2022 fhld Stock Issued During Period Issued For Services
StockIssuedDuringPeriodIssuedForServices
0 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2544 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
34273 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-244 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-350 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51706 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27775 usd
CY2023 fhld Issuance Of Common Stock For Acquisition
IssuanceOfCommonStockForAcquisition
44500 usd
CY2022 fhld Issuance Of Common Stock For Acquisition
IssuanceOfCommonStockForAcquisition
0 usd
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
2617 usd
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
26800 usd
CY2023 us-gaap Estimate Of Cancellations
EstimateOfCancellations
0 usd
CY2022 us-gaap Estimate Of Cancellations
EstimateOfCancellations
-980 usd
CY2023 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
5000 usd
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52117 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25820 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
411 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1955 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2132 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
11843 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
12620 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
177 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
254000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10177748 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-399918 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2023 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
330 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
574 usd
CY2023Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
126680 usd
CY2022Q3 fhld Note Payable And Accrued Interest
NotePayableAndAccruedInterest
124307 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241297 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
243654 usd
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55308825 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9308825 shares
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
84000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
13000 usd
CY2023 fhld Federal Income Taxes Valuation Allowance
FederalIncomeTaxesValuationAllowance
-84000 usd
CY2022 fhld Federal Income Taxes Valuation Allowance
FederalIncomeTaxesValuationAllowance
-13000 usd
CY2023 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
254000 usd
CY2022Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
170000 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
254000 usd
CY2022Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
170000 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
254000 usd

Files In Submission

Name View Source Status
0001477932-24-000342-index-headers.html Edgar Link pending
0001477932-24-000342-index.html Edgar Link pending
0001477932-24-000342.txt Edgar Link pending
0001477932-24-000342-xbrl.zip Edgar Link pending
fhld-20230930.xsd Edgar Link pending
fhld_10k.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
fhld-20230930_cal.xml Edgar Link unprocessable
fhld-20230930_lab.xml Edgar Link unprocessable
fhld-20230930_pre.xml Edgar Link unprocessable
fhld_10k_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
fhld-20230930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable